HomeLoansRapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

Article content

BURLINGTON, Ontario — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that it has closed on $230,000 in a first tranche of its previously announced (May 26, 2022) private placement financing (the “Financing”) for up to $5,000,000 of gross proceeds, consisting of up to 5,000 units (the “Units”) at a price of $1,000 per Unit. Each Unit consists of $1,000 principal amount of unsecured convertible notes (the “Notes”) and 100 common share purchase warrants of the Company (the “Warrants”).

Article content

On this first tranche closing, 230 Units were purchased; and accordingly, the Company issued $230,000 principal amount of Notes and 23,000 Warrants.

The Notes have a maturity date of 24 months from the closing date and bear…

Read more at financialpost.com

RELATED ARTICLES
- Advertisment -

Most Popular